PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Case Study

Volume 4 Issue 3

Case Study and Protocol for Natural Ingredients used to Support Breast Cancer Patients

Christina Rahm*

August 16, 2024

DOI : 10.56831/PSSRP-04-130

View PDF

Abstract

Breast cancer remains a significant global health issue, prompting the need for further exploration of alternatives to conventional treatments. Through the years, this has led to the formulation and investigation of protocols using natural ingredients as potential remedies for holistic control of breast cancer. An integrated protocol with a case study of a 58-year-old woman diagnosed with breast carcinoma will be discussed to ascertain this approach. The case study details the patient's discovery of a lump, followed by a detailed analysis using more precise breast imaging methods. The examination identified a hypoechoic and dense tumor in her right breast. The subsequent core biopsy confirmed the diagnosis of carcinoma lobular mammae, emphasizing the necessity for an effective and personalized therapeutic approach.

References

  1. Akrom A and Darmawan E. “Tolerability and safety of black cumin seed oil (Bcso) administration for 20 days in healthy subjects”. Biomedical Research-Tokyo 28.9 (2017): 4196-4201.
  2. Alamolhodaei NS., et al. “Resveratrol as MDR reversion molecule in breast cancer: An overview”. Food and Chemical Toxicology 103 (2017): 223-232.
  3. Angarita FA., et al. “Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence”. Breast Cancer Research and Treatment 171.3 (2018): 545-564.
  4. Ballout F., et al. “Thymoquinone-based nanotechnology for cancer therapy: promises and challenges”. Drug Discovery Today 23.5 (2018): 1089-1098.
  5. Chaudhry S., et al. Blackseed (Nigella sativa) Oil and its Active Ingredient, Thymoquinone, Suppress the Aggressive Phenotype of Breast Cancer Cells 14.2 14(2) (2017).
  6. Choi EJ., et al. “Evaluation of the in vitro/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase”. Food and Chemical Toxicology 72 (2014): 13-19.
  7. Estrada-Pérez AR., et al. “Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid”. International Journal of Molecular Sciences 23.5 (2022): 2645.
  8. Fabianowska-Majewska K., et al. “Curcumin from Turmeric Rhizome: A Potential Modulator of DNA Methylation Machinery in Breast Cancer Inhibition”. Nutrients 13.2 (2021): 332.
  9. Fakhari S., et al. “Aloe-emodin Induces Apoptosis through the Up-Regulation of Fas in the Human Breast Cancer Cell Line MCF-7”. Life Science Journal (2014).
  10. Ford S, Schofield T and Hope T. “What are the ingredients for a successful evidence-based patient choice consultation?: A qualitative study”. Social Science & Medicine 56.3 (2003): 589-602.
  11. Ji Young You, Park S and Eun Sook Lee. “Brief Overview of Breast Cancer Treatment”. In: Lee, E.S. (eds) A Practical Guide to Breast Cancer Treatment (2023): 147-171.
  12. Jiang X., et al. “Aloe-Emodin Induces Breast Tumor Cell Apoptosis through Upregulation of miR-15a/miR-16-1 That Suppresses BCL2”. Evidence-Based Complementary and Alternative Medicine (2020): 1-10.
  13. Kavita J., et al. “Knowledge, attitude and practice of complementary and alternative medicine: A patient’s perspective”. International Journal of Medicine & Public Health 5.1 (2015): 19-23.
  14. Lopes CM, Dourado A and Oliveira R. “Phytotherapy and Nutritional Supplements on Breast Cancer”. BioMed Research International (2017).
  15. Rani M, Dwivedi V and Dhingra HK. “Anticancerous Activity of Green Synthesized Silver Nanoparticle of Apple Cider Vinegar”. NeuroQuantology 20.22 (2022): 2094-2105.
  16. Sinha D., et al. “Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms”. Seminars in Cancer Biology 40-41 (2016): 209-232.
  17. Waks AG and Winer EP. “Breast Cancer Treatment”. JAMA 321.3 (2019): 288-300.
  18. Wright Laura E., et al. “Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer”. Current Pharmaceutical Design 19.34 (2013): 6218-6225.
  19. Zulkipli AF., et al. “Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report from the MyBCC Study”. Integrative Cancer Therapies 17.2 (2017): 312-321.